The treatment of comorbid posttraumatic stress disorder and major depressive disorder: The utility of a combined treatment approach.

Not Applicable

Recruiting

• Conditions: Posttraumatic Stress Disorder; Depression; Mental Health - Anxiety; Mental Health - Depression

• Registration Number: ACTRN12611000541909
• Lead Sponsor: Samantha Angelakis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-05-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Participants will be recruited if they: (a) are fluent in English, (b) have been exposed directly or indirectly (witnessed) to trauma (motor vehicle accidents, industrial accidents, interpersonal assault etc) four or more weeks ago, (c) meet a full or sub-threshold diagnosis for Post Traumatic Stress Disorder and (d) if participants are on psychotropic medications, agree to maintain a stable course of medication for the duration of therapy.

Exclusion Criteria

Exclusion criteria
Exclusion criteria for research purposes comprise: inadequate comprehension of English. For clinical reasons, clients with the following presentations would not normally be offered short-term trauma-focussed therapy in any service: (a) moderate to severe traumatic brain injury, (b) uncontrolled psychosis, (c) current substance dependence, (d) already currently in an active, trauma-focussed therapy, (e) significant risk of harm (e.g. in current domestic violence situation) or (f) active suicidality.

Withdrawal criteria
As a matter of standard clinical management and ethical procedures, participants would be withdrawn if it was felt that therapy was either inappropriate or if there was a significant decline in the person’s well-being (e.g., if they required hospitalisation for self-harm concerns etc).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary Outcome 1: Posttraumatic Stress Disorder Check List score (posttraumatic stress disorder symptom measure)[Timepoint: Pre-treatment, mid treatment, post-treatment, 6 month follow up];Primary Outcome 2: Mean Depression, Anxiety and Stress Scale score (depression symptom measure)[Timepoint: Pre-treatment, mid treatment, post-treatment, 6 month follow up]